This inventor holds 1 USPTO granted patent. Top assignee: Fcb-Pharmicell Co., Ltd.. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: Innovations of Hong Ki Jun in Adenosine Deaminase Inhibition
Introduction
Hong Ki Jun is a notable inventor based in Busan, South Korea. He has made significant contributions to the field of biochemistry, particularly in the development of adenosine deaminase inhibitors. His work has implications for antibacterial and anticancer therapies, showcasing the potential of his inventions in medical applications.
Latest Patents
Hong Ki Jun holds 1 patent related to an adenosine deaminase inhibitor. This invention involves a novel strain, IADA-7, which produces the adenosine deaminase inhibitor. The inhibitor demonstrates superior antibacterial and anticancer activities compared to previously reported compounds in this category.
Career Highlights
He is currently associated with Fcb-Pharmicell Co., Ltd., where he continues to innovate and contribute to advancements in pharmaceutical research. His work at the company emphasizes the importance of developing effective therapeutic agents.
Collaborations
Hong Ki Jun collaborates with esteemed colleagues, including Gwang Hwan Lee and Young Hwan Ahn. Their combined expertise enhances the research and development efforts within their field.
Conclusion
Hong Ki Jun's contributions to the development of adenosine deaminase inhibitors highlight his role as an influential inventor in the pharmaceutical industry. His innovative work has the potential to lead to significant advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile